Abstract:Previous studies have revealed that activation of the Toll‑like receptor 4 (TLR4)‑mediated proinflammatory signaling pathway plays an important role in acute inflammation, sepsis and chronic inflammatory disorders. Moreover, TLR4 significantly contributes to lipopolysaccharide (LPS)‑induced immune response. Thus, modulation of the TLR4 pathway is an important strategy to specifically target these pathologies. The aim of the present study was to develop a complete human anti‑TLR4 IgG2 antibody by screening human TLR4 Fab from a phage‑display library and integrating it with constant regions of the heavy chain of human IgG2 via antibody engineering. ELISA, a BLItz system and fluorescence‑activated cell sorting were used to assess its affinity. Furthermore, mouse‑derived peritoneal macrophages were treated with human anti‑TLR4 IgG2 and induced with LPS in vitro. Reverse transcription‑quantitative PCR and western blotting were used to determine mRNA expression levels of cytokines and phosphorylation levels of signaling pathways, respectively. It was found that human anti‑TLR4 IgG2 bound to TLR4 with a high affinity of 8.713x10‑10 M, and that preincubation with anti‑TLR4 IgG2 inhibited the LPS‑induced production of tumor necrosis factor‑α, interferon‑β and interleukin‑6 mRNA expression levels in mouse peritoneal macrophages. It was also demonstrated that human anti‑TLR4 IgG2 inhibited LPS‑induced TLR4 signaling by reducing the phosphorylation of the NF‑κB, mitogen‑activated protein kinase and interferon regulatory factor 3 signaling pathways. In addition, human anti‑TLR4 IgG2 protected mice from LPS challenge with a survival rate of 40% and also significantly increased the survival time in the cecal ligation and puncture model. Therefore, it was speculated that human anti‑TLR4 IgG2 plays a protective role against sepsis‑associated injury and is potentially applicable for the treatment of infection‑associated immune dysfunction.

Murine TLR2 expression analysis and systemic antagonism by usage of specific monoclonal antibodies.

Cellular Recognition of Trimyristoylated Peptide or Enterobacterial Lipopolysaccharide Via Both TLR2 and TLR4*

Antagonistic Antibody Prevents Toll-Like Receptor 2–driven Lethal Shock-Like Syndromes

Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation

Endotoxin-mimetic Effect of Antibodies Against Toll-like Receptor 4.

Contribution Of Toll-Like Receptor 2 To The Innate Response Against Staphylococcus Aureus Infection In Mice

Protective Effect of an Antibody Against Specific Extracellular Domain of TLR2 on Agonists-Driven Inflammatory and Allergic Response.

Human but Not Murine Toll-like Receptor 2 Discriminates Between Tri-palmitoylated and Tri-lauroylated Peptides

Human monoclonal anti‐TLR4 antibody negatively regulates lipopolysaccharide‐induced inflammatory responses in mouse macrophages

Toll-like Receptor (TLR)2 and TLR3 Synergy and Cross-Inhibition in Murine Myeloid Dendritic Cells

Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling

Assembly of the TLR2/6 Transmembrane Domains Is Essential for Activation and Is a Target for Prevention of Sepsis

TLR2 Promotes Monocyte/Macrophage Recruitment into the Liver and Microabscess Formation to Limit the Spread of Listeria Monocytogenes.

The Fab Fragment of a Humanized Anti-Toll Like Receptor 4 (TLR4) Monoclonal Antibody Reduces the Lipopolysaccharide Response Via TLR4 in Mouse Macrophage

Exploring Species-Specificity in TLR4/MD-2 Inhibition with Amphiphilic Lipid A Mimicking Glycolipids

Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium Tuberculosis Infection

A novel CCR-2/TLR-2 triggered signaling in murine peritoneal macrophages intensifies bacterial (Staphylococcus aureus) killing by reactive oxygen species through TNF-R1

Forward Genetic Analysis of TLR Pathways

Analysis of Monocyte Cell Fate by Adoptive Transfer in a Murine Model of TLR7-induced Systemic Inflammation

Protective Effect of a Novel Antibody Against TLR2 on Zymosan-Induced Acute Peritonitis in NF-κB Transgenic Mice.

Role of Toll-like Receptor 2 Against Streptococcus Uberis Infection in Primary Mouse Mammary Epithelial Cells